# INSITE (NCT03686215)

> Investigation of Novel Surgical Imaging for Tumor Excision

No report yet. It can be ordered.

- Indication: breast cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03686215
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Lumicell, Inc.
- Conditions: Breast Cancer
- Interventions: Study Device Arm
- Enrollment: 406
- Primary outcome: Percentage of Patients Who Had Residual Cancer Found in at Least One LUM Imaging System Guided Shave Among All Patients.
- Primary outcome: Sensitivity of LUM Imaging System on Cancer in the Lumpectomy Cavity
- Primary outcome: Specificity of LUM Imaging System Detection on Cancer in the Lumpectomy Cavity

## Indexed commentary on INSITE so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 5 posts on X
- 1 podcast episode

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=insite-nct03686215